/Quest%20Diagnostics%2C%20Inc_%20logo%20on%20building-by%20Tada%20Images%20via%20Shutterstock.jpg)
Valued at a market cap of $18.2 billion, Quest Diagnostics Incorporated (DGX) provides diagnostic testing and services in the United States and internationally. Founded in 1967 and based in Secaucus, New Jersey, DGX develops and delivers diagnostic information services. The company is expected to announce its fiscal Q1 earnings results on Tuesday, Apr. 22, before the market opens.
Ahead of this event, analysts project the company to report a profit of $2.16 per share, up 5.9% from $2.04 per share in the year-ago quarter. The company has beaten Wall Street's EPS estimates in all of the last four quarters, which is impressive.